Cargando…
Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial
OBJECTIVE: To identify genetic determinants of increased cardiovascular mortality among subjects with type 2 diabetes who underwent intensive glycemic therapy in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND METHODS: A total of 6.8 million common variants...
Autores principales: | Shah, Hetal S., Gao, He, Morieri, Mario Luca, Skupien, Jan, Marvel, Skylar, Paré, Guillaume, Mannino, Gaia C., Buranasupkajorn, Patinut, Mendonca, Christine, Hastings, Timothy, Marcovina, Santica M., Sigal, Ronald J., Gerstein, Hertzel C., Wagner, Michael J., Motsinger-Reif, Alison A., Buse, John B., Kraft, Peter, Mychaleckyj, Josyf C., Doria, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079609/ https://www.ncbi.nlm.nih.gov/pubmed/27527847 http://dx.doi.org/10.2337/dc16-0285 |
Ejemplares similares
-
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical Trial
por: Morieri, Mario Luca, et al.
Publicado: (2018) -
Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD
por: Shah, Hetal S., et al.
Publicado: (2018) -
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid
por: Morieri, Mario Luca, et al.
Publicado: (2020) -
The Impact of Precision Medicine in Diabetes: A Multidimensional Perspective
por: Rich, Stephen S., et al.
Publicado: (2016) -
ToxPi*GIS Toolkit: Creating, viewing, and sharing integrative visualizations for geospatial data using ArcGIS
por: Fleming, Jonathon, et al.
Publicado: (2021)